Newsk4xqd2025-02-17T14:10:32+00:00

News

Procedures for the development of orphan drugs
Continue reading
Key steps in the preclinical development of a drug
Continue reading
Challenges and solutions in the development of drugs for rare diseases
Continue reading
Advertising for medicines: promoting while complying with French regulations
Continue reading
Post-marketing pharmacovigilance obligations in Europe
Continue reading
How to market a drug in France? Centralized Marketing Authorization and other cases
Continue reading
Early access and compassionate use: making a drug available when not authorized in France
Continue reading
What are the EMA’s timelines for the standard and accelerated procedures?
Continue reading
Understanding the differences between the FDA and the EMA: strategic implications for market access
Continue reading
Pharmaceutical patents: how to protect the intellectual property of a healthcare innovation?
Continue reading
Requirements for compliant manufacturing of biotechnological products
Continue reading
How to manage regulatory variations of a Marketing Authorisation (MA)?
Continue reading